INCREASING THE ED RESEARCH FOOTPRINT
Health Careers: Advice from an Emergency Physician in Research
Associate Professor Viet Tran, Emergency Physician, Royal Hobart Hospital
Filmed Hobart, Tasmania | September 2024
Associate Professor Viet Tran, an experienced emergency physician at the Royal Hobart Hospital. He spoke with Australian Health Journal about the crucial role of emergency departments as the frontline of hospitals, providing immediate care, diagnosis, resuscitation, and serving as a safety net for the healthcare system. Prof. Tran highlights the importance of understanding the daily responsibilities and core aspects of a specialty when choosing a medical career.
Recognising the relatively young status of emergency medicine as a specialty, Prof. Tran has taken on leadership roles to advance research in this field. In 2019, he became the Director of Emergency Medicine Research with the Tasmanian Department of Health, aiming to enhance the research footprint and collaboration within the specialty. His efforts have led to collaborations with national networks such as the PREDICT network and the National COVID research for ED, ultimately contributing to the development of emergency medicine research infrastructure in Tasmania.
Currently, Prof. Tran is leading a major MRFF study focusing on implementing clinical pathways in Tasmania to expedite the translation of research findings into improved patient care. This specific focus on this initiative is to minimise variations in patient care and address health inequities in rural and regional emergency department settings.
Associate Professor Viet Tran’s roles;
- Deputy Director of Emergency Medicine at Royal Hobart Hospital
- Associate Professor of Emergency Medicine, University of Tasmania,
- Founding Director, Tasmanian Emergency Medicine Research Institute
- Chair of the Tasmanian Emergency Departments Network
- Board Member, Emergency Medicine Foundation
- Co-Chair of the Tasmanian Health Senate
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
